Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 6 pseudogene 1 (RNF6P1) is classified as a pseudogene in humans, meaning it is a non-functional segment of DNA that resembles the coding gene RNF6 but does not produce a functional protein product[6]. Pseudogenes can arise from gene duplication or retrotransposition events and often accumulate mutations that prevent their translation or function. There is no evidence in the scientific literature that RNF6P1 serves as a therapeutic target, participates in known biological functions, or is involved in disease biology as a functional gene. The functional form, RNF6, encodes a RING-domain E3 ubiquitin ligase implicated in processes such as ubiquitination and signal transduction, but RNF6P1 itself is not an active target and should not be confused with the functional gene[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 6 pseudogene 1 (RNF6P1).